Celesia, Benedetto Maurizio, Andrea Marino, Rosa Fontana del Vecchio, Roberto Bruno, Filippo Palermo, Maria Gussio, Giuseppe Nunnari, and Bruno Cacopardo. “IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?”. Mediterranean Journal of Hematology and Infectious Diseases 11, no. 1 (October 30, 2019): e2019063. Accessed July 7, 2020. http://mjhid.org/index.php/mjhid/article/view/2019.063.